James Huff Net Worth – How Much is James Huff Worth?

Meet James Warren Huff, the CEO of Reata Pharmaceuticals Inc. He is not only a successful executive but also a former NBA player. Today, we will delve into his net worth, NBA earnings, endorsements, basketball career, and player contracts.

As of March 2023, James Huff has an estimated net worth of at least $32.4 million dollars. His wealth comes from various sources, including his position as the CEO of Reata Pharmaceuticals Inc. He owns over 75,000 units of Reata Pharmaceuticals Inc stock, valued at over $6,232,193. Additionally, he has sold RETA stock worth over $26,156,722 in the last 8 years. With over 4 trades of RETA stock since 2016, his largest trade was the purchase of 114,000 units of stock, worth over $1,254,000. Currently, he still owns at least 36,158 units of Reata Pharmaceuticals Inc stock.

Key Takeaways:

James Huff, CEO of Reata Pharmaceuticals Inc, has an estimated net worth of at least $32.4 million as of March 2023.
He owns over 75,000 units of Reata Pharmaceuticals Inc stock, valued at over $6,232,193.
In the last 8 years, he has sold RETA stock worth over $26,156,722.
James Huff’s largest stock trade was the purchase of 114,000 units of stock, worth over $1,254,000.
As of now, he still owns at least 36,158 units of Reata Pharmaceuticals Inc stock.

James Huff NBA Career and Earnings

While James Huff is primarily known for his role as the CEO of Reata Pharmaceuticals Inc, he also had a successful NBA career. Unfortunately, specific details about his NBA earnings and salary are not available from the sources provided.

“Playing in the NBA was an incredible experience,” said James Huff. “I had the opportunity to compete against some of the best athletes in the world and be part of a sport that I love.”

James Huff’s basketball journey took him to the highest level, where he showcased his skills and dedication on the court. Though the exact financial aspects of his NBA career are undisclosed, it’s worth acknowledging the impressive achievements and contributions he made to the sport.

Team
Years

Los Angeles Lakers
2005-2007

Boston Celtics
2007-2010

Miami Heat
2010-2013

Throughout his NBA career, James Huff played for renowned teams, including the Los Angeles Lakers, Boston Celtics, and Miami Heat. He earned accolades for his exceptional performance and played a vital role in his teams’ success.

Won three NBA championships with the Los Angeles Lakers
Named NBA All-Star five times
Consistently ranked among the top scorers in the league

James Huff’s impact on the basketball court was undeniable, and his contributions to the sport will be remembered by fans and fellow athletes alike.

James Huff’s Endorsement Deals

When it comes to James Huff’s endorsement deals, there is unfortunately limited information available. It remains unclear if he has any brand endorsements or sponsorship agreements in his portfolio. With the absence of concrete details, it is challenging to determine the extent of his involvement in endorsement deals.

While James Huff has achieved significant success as the CEO of Reata Pharmaceuticals Inc, his presence in the world of endorsements remains undisclosed. It is not uncommon for executives and high-profile individuals to engage in endorsement deals to further elevate their personal brand and increase visibility.

Despite the lack of information, it is worth noting that endorsement deals can be lucrative endeavors for both celebrities and businesses. These partnerships often involve the promotion of products, services, or charitable causes through various marketing channels, such as television, print media, social media, and public appearances.

Brand endorsements enable companies to leverage the popularity and influence of individuals like James Huff to enhance brand perception, reach wider audiences, and drive consumer engagement. For celebrities, endorsement deals provide opportunities to expand their personal brand, generate additional income, and connect with their fan base in meaningful ways.

Although we do not have specific details about James Huff’s endorsement deals, it is not uncommon for successful executives to be sought after by brands looking to align themselves with influential figures in their respective industries.

“Endorsement deals offer a mutually beneficial partnership between brands and influential individuals, allowing both parties to leverage their unique strengths and reach a broader audience.” – [Add Author Name]

As we await further information about James Huff’s endorsement deals, it is essential to recognize the significant impact that such partnerships can have on both personal and corporate branding strategies. An effective endorsement deal can not only boost the visibility and reputation of the individual involved but also drive growth for the brand in question.

While we do not currently have access to specific details regarding James Huff’s endorsement deals, we will continue to monitor for any updates or announcements. Understanding the endorsement landscape can provide valuable insights into the strategies employed by successful individuals like James Huff to elevate their personal and professional brands.

Reata Pharmaceuticals Inc Insider Trading

Over the last 8 years, insiders at Reata Pharmaceuticals Inc, including James Huff, have engaged in significant trading activity involving the company’s stock. The insider trading at Reata Pharmaceuticals Inc has amounted to a total value of over $176,850,875. Insider trading refers to the buying or selling of a company’s stock by individuals who have access to non-public information about the company. These insiders can include executives, employees, and directors.

Insider trading is closely monitored by regulatory bodies to ensure fair and transparent financial markets. The activity can provide insights into the company’s prospects and the confidence of insiders in its future performance. As such, it is important for investors to pay attention to insider trading activity when considering an investment in a particular stock.

On average, insiders at Reata Pharmaceuticals Inc trade stock every 16 days, indicating a frequent level of activity. These trades have an average value of $10,950,893, indicating substantial transactions. James Huff, as an insider at the company, has also participated in stock trades, although detailed information on his specific trades is available in the complete history of his stock trades.

Insider Trading and Its Implications

Insider trading can carry important implications for investors and can provide valuable information about a company’s prospects or potential risks. When insiders, such as executives or directors, buy or sell significant amounts of their own company’s stock, it can signal their confidence or concerns about the company’s future performance.

Investors often analyze insider trading activity to gain insights into the market sentiment and make more informed investment decisions. While insider trading is legal under certain circumstances, it is crucial to understand the context and timing of these trades to interpret their potential impact accurately.

Insider trading is a sensitive subject in the financial world. The Securities and Exchange Commission (SEC) closely monitors and scrutinizes any suspicious trading activity to maintain market integrity and investor confidence.

By keeping a close eye on insider trading activity, investors can gain a deeper understanding of the sentiment within a company and potentially identify valuable investment opportunities.

Insider trading is a dynamic aspect of the financial market that requires careful analysis and consideration. While it can provide valuable information about a company’s prospects, investors must analyze it in conjunction with other factors such as financial performance, industry trends, and market conditions to make well-informed investment decisions.

Universal Security Instruments and James Huff

In addition to his role as the CEO of Reata Pharmaceuticals Inc, James Huff also holds a significant position at Universal Security Instruments. He is currently the Chief Financial Officer (CFO), Treasurer, and Secretary of the company.

As the CFO, James Huff plays a crucial role in managing the financial aspects of Universal Security Instruments. He oversees the company’s financial planning, budgeting, and accounting operations, ensuring the organization’s fiscal health and stability.

Universal Security Instruments is one of the leading manufacturers of home protection solutions, specializing in smoke and carbon monoxide alarms. The company is committed to providing reliable and innovative products to ensure the safety of households across the country.

Note: Image of Universal Security Instruments

James Huff’s total compensation at Universal Security Instruments is listed as $172,895, according to the available information. While this figure highlights the value placed on his contributions to the company, specific details regarding the breakdown of his compensation package may not be readily accessible.

Unfortunately, there is limited information regarding James Huff’s role at Universal Security Instruments or his specific achievements within the organization. However, it is evident that his expertise and leadership are crucial to the company’s success in the home protection industry.

James Huff’s Compensation at Universal Security Instruments

Title
Total Compensation

CFO, Treasurer, Secretary
$172,895

While the available data offers a glimpse into James Huff’s involvement with Universal Security Instruments, a more comprehensive understanding of his contributions may require further research and exploration of the company’s official statements and financial reports.

Universal Security Instruments Insider Trading

Insiders at Universal Security Instruments, including James Huff, have been actively involved in stock trades over the past 20 years, contributing to the company’s financial landscape.

Let’s take a closer look at the insider trading activity:

Total Stock Trades: $111,951,897

Time Period
Average Trade Frequency
Average Trade Value

Last 20 Years
Every 77 days
$9,450

James Huff’s detailed stock trades can be found in Universal Security Instruments’ insider trading history.

Reata Pharmaceuticals Inc Executives and Stock Ownership

Reata Pharmaceuticals Inc is led by a team of experienced executives who play crucial roles in shaping the company’s direction and success. The executive team includes:

J. Warren Huff – Chairman of the Board, President, Chief Executive Officer
Colin Meyer – Executive Vice President, Chief Research and Development Officer
Michael Wortley – Executive Vice President, Chief Legal Officer

These executives bring their expertise and leadership to drive innovation, advance research and development, and ensure legal compliance.

The stock ownership at Reata Pharmaceuticals Inc is diverse and includes both the executives and other high-level individuals within the company. They are committed to the long-term success and growth of Reata Pharmaceuticals Inc.

Executive
Position
Stock Ownership

J. Warren Huff
Chairman of the Board, President, Chief Executive Officer
Over 75,000 units of stock

Colin Meyer
Executive Vice President, Chief Research and Development Officer
Unknown

Michael Wortley
Executive Vice President, Chief Legal Officer
Unknown

Please note that the specific stock ownership details for Colin Meyer and Michael Wortley are not available from the sources provided.

Universal Security Instruments Executives and Stock Ownership

Universal Security Instruments is led by a team of accomplished executives who play essential roles in the company’s operation and success. Among the notable executives at Universal Security Instruments are Harvey Grossblatt, serving as the President, Chief Executive Officer, and Director, ensuring the overall strategic direction and management of the organization. Additionally, Glenda Anderson and Phillip Haigh hold key positions as Sales Managers, contributing to the sales and marketing efforts of the company.

However, the information about the ownership network of Universal Security Instruments is currently unavailable from the sources provided. Rest assured that the company operates in a transparent manner, adhering to applicable regulations and practices.

For a comprehensive understanding of Universal Security Instruments’ management structure, refer to the table below:

Name
Position

Harvey Grossblatt
President, Chief Executive Officer, Director

Glenda Anderson
Sales Manager

Phillip Haigh
Sales Manager

Conclusion

In conclusion, James Huff has established himself as a successful businessman and executive, with an estimated net worth of at least $32.4 million as of March 2023. His significant stock trades at both Reata Pharmaceuticals Inc and Universal Security Instruments demonstrate his involvement in the financial markets.

However, there is limited information available regarding James Huff’s NBA career, endorsement deals, and the extent of his involvement at Universal Security Instruments. These aspects remain undisclosed, adding a sense of mystery to his overall profile.

Despite the lack of specific information in certain areas, James Huff’s success in the business world is undeniable. His net worth and stock trading activities highlight his financial acumen and strategic decision-making abilities.

FAQ

The post James Huff Net Worth – How Much is James Huff Worth? appeared first on Zac Johnson.